Graph representation learning aims to effectively encode high-dimensional sparse graph- structured data into low-dimensional dense vectors, which is a fundamental task that has …
Generative models, especially diffusion models (DMs), have achieved promising results for generating feature-rich geometries and advancing foundational science problems such as …
Structure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. Generative SBDD methods …
Rich data and powerful machine learning models allow us to design drugs for a specific protein target\textit {in silico}. Recently, the inclusion of 3D structures during targeted drug …
O Zhang, J Zhang, J Jin, X Zhang, RL Hu… - Nature Machine …, 2023 - nature.com
Most molecular generative models based on artificial intelligence for de novo drug design are ligand-centric and do not consider the detailed three-dimensional geometries of protein …
Y Song, J Gong, M Xu, Z Cao, Y Lan… - Advances in …, 2024 - proceedings.neurips.cc
The generation of 3D molecules requires simultaneously deciding the categorical features (atom types) and continuous features (atom coordinates). Deep generative models …
Advances in artificial intelligence (AI) are fueling a new paradigm of discoveries in natural sciences. Today, AI has started to advance natural sciences by improving, accelerating, and …
Y Zhang, M Luo, P Wu, S Wu, TY Lee, C Bai - International journal of …, 2022 - mdpi.com
Traditional drug design requires a great amount of research time and developmental expense. Booming computational approaches, including computational biology, computer …
Generating molecules that bind to specific proteins is an important but challenging task in drug discovery. Previous works usually generate atoms in an auto-regressive way, where …